{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:53:21Z","timestamp":1791809601408,"version":"4.3.4"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.redox.2025.103846","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:34:59Z","timestamp":1756308899000},"page":"103846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Mechanisms, therapeutic uses, and developmental perspectives of redox-active thiomolybdates"],"prefix":"10.1016","volume":"86","author":[{"given":"Yihan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid S.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Dal-Pizzol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8334-9432","authenticated-orcid":false,"given":"Alex","family":"Dyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2025.103846_bib1","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.redox.2025.103846_bib2","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1039\/b705551j","article-title":"Metal based drugs: from serendipity to design","volume":"43","author":"Fricker","year":"2007","journal-title":"Dalton Trans."},{"key":"10.1016\/j.redox.2025.103846_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3184\/003685014X13898980185076","article-title":"Metal-based drugs","volume":"97","author":"McQuitty","year":"2014","journal-title":"Sci. Prog."},{"key":"10.1016\/j.redox.2025.103846_bib4","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/s41467-022-29566-0","article-title":"Structure of the active pharmaceutical ingredient bismuth subsalicylate","volume":"13","author":"Svensson Grape","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2025.103846_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/bja\/42.10.859","article-title":"Sodium nitroprusside as a hypotensive agent in general anaesthesia","volume":"42","author":"Taylor","year":"1970","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.redox.2025.103846_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/d41573-024-00001-x","article-title":"2023 FDA approvals","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2025.103846_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chempr.2019.10.013","article-title":"Classification of metal-based drugs according to their mechanisms of action","volume":"6","author":"Boros","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.redox.2025.103846_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/andp.18260830702","article-title":"Ueber die Schwefelsalze","volume":"83","author":"Berzelius","year":"1826","journal-title":"Ann. Phys."},{"key":"10.1016\/j.redox.2025.103846_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlac.18842250102","article-title":"Ueber Die Schwefelverbindungen Des Molybd\u00e4ns","volume":"225","author":"Kr\u00fcss","year":"1884","journal-title":"Justus Liebigs Ann. Chem."},{"key":"10.1016\/j.redox.2025.103846_bib11","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1158\/1078-0432.CCR-08-0315","article-title":"Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors","volume":"14","author":"Lowndes","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib12","author":"Wennerberg"},{"key":"10.1016\/j.redox.2025.103846_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2021.100117","article-title":"A review on chemical and physical properties of tetrathiomolybdate (TTM) anion drug is useful for TTM treated diseases","volume":"98","author":"Maiti","year":"2021","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.redox.2025.103846_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/141553a0","article-title":"Action of molybdenum in nutrition of milking cattle","volume":"141","author":"Ferguson","year":"1938","journal-title":"Nature"},{"key":"10.1016\/j.redox.2025.103846_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1017\/S002185960004836X","article-title":"The teart pastures of Somerset: I. The cause and cure of teartness","volume":"33","author":"Ferguson","year":"1943","journal-title":"J. Agric. Sci."},{"key":"10.1016\/j.redox.2025.103846_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S0021859600062468","article-title":"Thiomolybdates and the copper-molybdenum-sulphur interaction in ruminant nutrition","volume":"85","author":"Dick","year":"1975","journal-title":"J. Agric. Sci."},{"key":"10.1016\/j.redox.2025.103846_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/bj0720365","article-title":"The copper content and cytochrome oxidase activity of tissues from normal and swayback lambs","volume":"72","author":"Howell","year":"1959","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2025.103846_bib18","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1038\/185020a0","article-title":"Demyelination in lambs born of ewes maintained on high intakes of sulphate and molybdate","volume":"185","author":"Mills","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.redox.2025.103846_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1079\/BJN19880036","article-title":"Studies of the changes in systemic copper metabolism and excretion produced by the intravenous administration of trithiomolybdate in sheep","volume":"59","author":"Mason","year":"1988","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.redox.2025.103846_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0946-672X(11)80042-8","article-title":"Systemic dispositions of molybdenum and copper after tetrathiomolybdate injection in LEC rats","volume":"9","author":"Ogra","year":"1995","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.redox.2025.103846_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1039\/C6MT00103C","article-title":"Ceruloplasmin and other copper binding components of blood plasma and their functions: an update","volume":"8","author":"Linder","year":"2016","journal-title":"Metallomics"},{"key":"10.1016\/j.redox.2025.103846_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/13543780802621859","article-title":"The use of copper-lowering therapy with tetrathiomolybdate in medicine","volume":"18","author":"Brewer","year":"2009","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.redox.2025.103846_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0162-0134(87)80002-8","article-title":"Effect of molybdenum treatments on the distribution of Cu and metallothionein in tissue extracts from rats and sheep","volume":"31","author":"Allen","year":"1987","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.redox.2025.103846_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1079\/BJN19840081","article-title":"Some studies on the metabolism and the effects of 99Mo- and 35S-Labelled Thiomolybdates aftertIntravenous Infusioniin Sheep","volume":"52","author":"Hynes","year":"1985","journal-title":"Bi. J. Nutr."},{"key":"10.1016\/j.redox.2025.103846_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0034-5288(18)30582-4","article-title":"Accumulation of copper on albumin in bovine plasma in vivo after intravenous trithiomolybdate administration","volume":"41","author":"Mason","year":"1986","journal-title":"Vet. Sci."},{"key":"10.1016\/j.redox.2025.103846_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1079\/BJN19810054","article-title":"Intravenous administration of thiomolybdate for the prevention and treatment of chronic copper poisoning in sheep","volume":"46","author":"Gooneratne","year":"1981","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.redox.2025.103846_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archneur.1991.00530130050019","article-title":"Initial therapy of patients with Wilson's disease with tetrathiomolybdate","volume":"48","author":"Brewer","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.redox.2025.103846_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2460\/ajvr.76.5.445","article-title":"Pharmacologic evaluation of ammonium tetrathiomolybdate after intravenous and oral administration to healthy dogs","volume":"76","author":"Chan","year":"2015","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.redox.2025.103846_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","article-title":"Wilson disease","volume":"4","author":"Cz\u0142onkowska","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.redox.2025.103846_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","article-title":"Wilson's disease","volume":"369","author":"Ala","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2025.103846_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nchembio.72","article-title":"Mechanisms for copper acquisition, distribution and regulation","volume":"4","author":"Kim","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2025.103846_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-444-63625-6.00005-7","article-title":"Pathogenesis of Wilson disease","volume":"142","author":"Scheiber","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.redox.2025.103846_bib34","doi-asserted-by":"crossref","first-page":"C768","DOI":"10.1152\/ajpcell.00417.2012","article-title":"Cellular glutathione plays a key role in copper uptake mediated by human copper transporter 1","volume":"304","author":"Maryon","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.redox.2025.103846_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10911-006-9003-7","article-title":"The role of copper in tumour angiogenesis","volume":"10","author":"Lowndes","year":"2005","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.redox.2025.103846_bib36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/13543784.2018.1482274","article-title":"WTX101 \u2013 an investigational drug for the treatment of wilson disease","volume":"27","author":"Weiss","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.redox.2025.103846_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.1179907","article-title":"Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation","volume":"327","author":"Alvarez","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.redox.2025.103846_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0162-0134(98)00012-9","article-title":"Targeting of tetrathiomolybdate on the copper accumulating in the liver of LEC rats","volume":"70","author":"Ogra","year":"1998","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.redox.2025.103846_bib39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jinorgbio.2010.04.001","article-title":"Effect of glutathione depletion on removal of copper from LEC rat livers by tetrathiomolybdate","volume":"104","author":"Ogra","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.redox.2025.103846_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0300-483X(95)03171-B","article-title":"Mechanisms of selective copper removal by tetrathiomolybdate from metallothionein in LEC rats","volume":"106","author":"Ogra","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.redox.2025.103846_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0300-483X(97)03636-6","article-title":"Outputs of hepatic copper and cadmium stimulated by tetrathiomolybdate (TTM) injection in Long-Evans Cinnamon (LEC) rats pretreated with cadmium, and in fischer rats pretreated with copper and cadmium","volume":"120","author":"Lai","year":"1997","journal-title":"Toxicol"},{"key":"10.1016\/j.redox.2025.103846_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0300-483X(93)90098-D","article-title":"Selective removal of copper bound to metallothionein in the liver of LEC rats by tetrathiomolybdate","volume":"83","author":"Suzuki","year":"1993","journal-title":"Toxicol"},{"key":"10.1016\/j.redox.2025.103846_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI115208","article-title":"Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis: a model of Wilson's disease","volume":"87","author":"Li","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2025.103846_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/00498254.2018.1443352","article-title":"Metabolic disposition of WTX101 (Bis-Choline tetrathiomolybdate) in a rat model of Wilson disease","volume":"49","author":"Plitz","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.redox.2025.103846_bib45","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archneur.1996.00550100103019","article-title":"Treatment of wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and Follow-up with zinc therapy","volume":"53","author":"Brewer","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.redox.2025.103846_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.60.3.379","article-title":"Treatment of wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and Follow-up with zinc therapy","volume":"60","author":"Brewer","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.redox.2025.103846_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneur.63.4.521","article-title":"Treatment of wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of wilson disease","volume":"63","author":"Brewer","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.redox.2025.103846_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.trsl.2009.05.002","article-title":"Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine","volume":"154","author":"Brewer","year":"2009","journal-title":"Transl. Res."},{"key":"10.1016\/j.redox.2025.103846_bib49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.1987.00520170020016","article-title":"Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy","volume":"44","author":"Brewer","year":"1987","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.redox.2025.103846_bib50","series-title":"Abstracts BMJ","article-title":"Efficacy and safety of ALXN1840 versus standard of care in Wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial","author":"Weiss","year":"2022"},{"key":"10.1016\/j.redox.2025.103846_bib51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2023.11.023","article-title":"Effects of tetrathiomolybdate on copper metabolism in healthy volunteers and in patients with Wilson disease","volume":"80","author":"Kirk","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2025.103846_bib52","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jtemb.2014.07.015","article-title":"The promise of copper lowering therapy with tetrathiomolybdate in the cure of cancer and in the treatment of inflammatory disease","volume":"28","author":"Brewer","year":"2014","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.redox.2025.103846_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","article-title":"Elevated copper and oxidative stress in cancer cells as a target for cancer treatment","volume":"35","author":"Gupte","year":"2009","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.redox.2025.103846_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10534-008-9174-3","article-title":"The role of copper in drug-resistant murine and human tumors","volume":"22","author":"Majumder","year":"2009","journal-title":"Biometals"},{"key":"10.1016\/j.redox.2025.103846_bib55","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1038\/s41467-021-27559-z","article-title":"Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis","volume":"12","author":"Ramchandani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2025.103846_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/01635589209514187","article-title":"Evidence for increased non-ceruloplasmin copper in early-stage human breast cancer serum","volume":"17","author":"Dabek","year":"1992","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.redox.2025.103846_bib57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jso.2930520311","article-title":"Serum and tissue trace elements in colorectal cancer","volume":"52","author":"Gupta","year":"1993","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.redox.2025.103846_bib58","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1177\/0300060518798507","article-title":"Association between serum copper levels and lung cancer risk: a meta-analysis","volume":"46","author":"Zhang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.redox.2025.103846_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1209156","article-title":"Copper in cancer: from limiting nutrient to therapeutic target","volume":"13","author":"Tang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.redox.2025.103846_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114791","article-title":"Copper in cancer: from pathogenesis to therapy","volume":"163","author":"Guan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.redox.2025.103846_bib61","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.3390\/cancers12123594","article-title":"The multifaceted roles of copper in cancer: a trace metal element with dysregulated metabolism, but also a target or a bullet for therapy","volume":"12","author":"Leli\u00e8vre","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.redox.2025.103846_bib62","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.3390\/ijms20205225","article-title":"The mechanisms underlying the cytotoxic effects of copper via differentiated embryonic chondrocyte gene 1","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2025.103846_bib63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2217\/nnm-2021-0374","article-title":"Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes","volume":"17","author":"Jiang","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.redox.2025.103846_bib64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","article-title":"The matrix in cancer","volume":"21","author":"Cox","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2025.103846_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-06-0524","article-title":"Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer","volume":"6","author":"Hassouneh","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.redox.2025.103846_bib66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2407-12-147","article-title":"Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-Fluorouracil and mitomycin C","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.redox.2025.103846_bib67","article-title":"Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible Factor-1\u03b1 in cancer cells","volume":"5","author":"Kim","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2025.103846_bib68","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1476-4598-9-206","article-title":"Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis","volume":"9","author":"Kumar","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.redox.2025.103846_bib69","first-page":"4854","article-title":"Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis","volume":"62","author":"Pan","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib70","first-page":"701","article-title":"Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NF?B signaling Cascade","volume":"1","author":"Pan","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib71","first-page":"617","article-title":"Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma","volume":"2","author":"Pan","year":"2003","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.redox.2025.103846_bib72","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1158\/1078-0432.CCR-09-1361","article-title":"Antiangiogenic tetrathiomolybdate protects against Her2\/Neu-Induced breast carcinoma by hypoplastic remodeling of the mammary gland","volume":"15","author":"Pan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1001\/archotol.131.3.204","article-title":"The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck","volume":"131","author":"Teknos","year":"2005","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.redox.2025.103846_bib74","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1158\/1541-7786.MCR-21-0250","article-title":"BRAFV600E-Driven lung adenocarcinoma requires copper to sustain autophagic signaling and processing","volume":"20","author":"Tsang","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib75","doi-asserted-by":"crossref","DOI":"10.1177\/11795549231204612","article-title":"The antitumor impact of combining hepatic artery ligation with copper chelators for liver cancer","volume":"17","author":"Zeng","year":"2023","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.redox.2025.103846_bib76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-4827(80)90051-8","article-title":"Endothelial cell phagokinesis in response to specific metal ions","volume":"130","author":"McAuslan","year":"1980","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.redox.2025.103846_bib77","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00005537-200104000-00024","article-title":"The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma","volume":"111","author":"Cox","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1016\/j.redox.2025.103846_bib78","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.mehy.2013.09.035","article-title":"Is copper chelation an effective anti-angiogenic strategy for cancer treatment?","volume":"81","author":"Antoniades","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.redox.2025.103846_bib79","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A","article-title":"Copper stimulates proliferation of human endothelial cells under culture","volume":"69","author":"Hu","year":"1998","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.redox.2025.103846_bib80","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.redox.2025.103846_bib81","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1039\/C5MT00149H","article-title":"Targeting copper in cancer therapy: \u2018copper That Cancer\u2019","volume":"7","author":"Denoyer","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/j.redox.2025.103846_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2013.02.003","article-title":"The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies","volume":"60","author":"Lee","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103846_bib83","doi-asserted-by":"crossref","first-page":"996S","DOI":"10.1093\/ajcn\/67.5.996S","article-title":"Copper, lysyl oxidase, and extracellular matrix protein cross-linking","volume":"67","author":"Rucker","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.redox.2025.103846_bib84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1078-0432.CCR-06-0171","article-title":"Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1","volume":"12","author":"Juarez","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib85","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1021\/bi982284u","article-title":"A structure-based mechanism for copper\u2212Zinc superoxide dismutase","volume":"38","author":"Hart","year":"1999","journal-title":"Biochemist"},{"key":"10.1016\/j.redox.2025.103846_bib86","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2025.103846_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-biophys-042910-155341","article-title":"Proton-pumping mechanism of cytochrome c oxidase","volume":"40","author":"Yoshikawa","year":"2011","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.redox.2025.103846_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103426","article-title":"Regulation of mitochondrial oxidative phosphorylation through tight control of cytochrome c oxidase in health and disease - implications for ischemia\/reperfusion injury, inflammatory diseases, diabetes, and cancer","volume":"78","author":"Pham","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103846_bib89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.redox.2025.103846_bib90","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.mito.2012.07.104","article-title":"Curbing cancer's sweet tooth: is there a role for MnSOD in regulation of the warburg effect?","volume":"13","author":"Holley","year":"2013","journal-title":"Mitochondrion"},{"issue":"48","key":"10.1016\/j.redox.2025.103846_bib91","doi-asserted-by":"crossref","first-page":"19507","DOI":"10.1073\/pnas.1318431110","article-title":"Bioavailable copper modulates oxidative phosphorylation and growth of tumors","volume":"110","author":"Ishida","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.redox.2025.103846_bib92","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrc2540","article-title":"The impact of O2 availability on human cancer","volume":"8","author":"Bertout","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2025.103846_bib93","doi-asserted-by":"crossref","first-page":"34158","DOI":"10.18632\/oncotarget.5779","article-title":"Copper activates HIF-1\u03b1\/GPER\/VEGF signalling in cancer cells","volume":"6","author":"Rigiracciolo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2025.103846_bib94","first-page":"6","article-title":"Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma","volume":"42","author":"Ryumon","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.redox.2025.103846_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-08102-z","article-title":"Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein","volume":"10","author":"Fang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2025.103846_bib96","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1039\/C8MT00084K","article-title":"Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1","volume":"10","author":"Tian","year":"2018","journal-title":"Metallomics"},{"key":"10.1016\/j.redox.2025.103846_bib97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/1535-7163.MCT-18-0667","article-title":"Inhibition of copper transport induces apoptosis in triple-negative breast cancer cells and suppresses tumor angiogenesis","volume":"18","author":"Karginova","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.redox.2025.103846_bib98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nchem.2381","article-title":"Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation","volume":"7","author":"Wang","year":"2015","journal-title":"Nat. Chem."},{"issue":"7501","key":"10.1016\/j.redox.2025.103846_bib99","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature13180","article-title":"Copper is required for oncogenic BRAF signalling and tumorigenesis","volume":"509","author":"Brady","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.redox.2025.103846_bib100","first-page":"7","article-title":"Novel role for copper in Ras\/mitogen-activated protein kinase signaling","volume":"32","author":"Turski","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2025.103846_bib101","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cancers11050659","article-title":"Effects of copper chelation on BRAFV600E positive Colon carcinoma cells","volume":"11","author":"Baldari","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.redox.2025.103846_bib102","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1158\/1078-0432.CCR-17-3705","article-title":"Copper chelation as targeted therapy in a mouse model of oncogenic BRAF-driven papillary thyroid cancer","volume":"24","author":"Xu","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib103","author":"Baumgart"},{"key":"10.1016\/j.redox.2025.103846_bib104","first-page":"1","article-title":"Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study","volume":"6","author":"Brewer","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib105","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1078-0432.CCR-16-1326","article-title":"Influencing the tumor microenvironment: a phase II study of copper depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence and in preclinical models of lung metastases","volume":"23","author":"Chan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10637-008-9165-9","article-title":"A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-Flurouracil, and leucovorin for metastatic colorectal cancer","volume":"27","author":"Gartner","year":"2009","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.redox.2025.103846_bib107","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000106066","article-title":"Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer","volume":"71","author":"Henry","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.redox.2025.103846_bib108","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/annonc\/mds654","article-title":"Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse","volume":"24","author":"Jain","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.redox.2025.103846_bib109","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.urolonc.2011.04.009","article-title":"A non-comparative randomized phase II study of 2 doses of ATN-224, a copper\/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-na\u00efve prostate cancer","volume":"31","author":"Lin","year":"2013","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.redox.2025.103846_bib111","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.athoracsur.2008.03.016","article-title":"A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results","volume":"86","author":"Pass","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.redox.2025.103846_bib112","first-page":"5","article-title":"Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer","volume":"9","author":"Redman","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103846_bib114","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1067\/mlc.2003.20","article-title":"Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice","volume":"141","author":"Brewer","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.redox.2025.103846_bib115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/153537020422900820","article-title":"Tetrathiomolybdate therapy protects against concanavalin A and carbon tetrachloride hepatic damage in mice","volume":"229","author":"Askari","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.redox.2025.103846_bib116","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.107.131227","article-title":"Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis","volume":"325","author":"Song","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.redox.2025.103846_bib117","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jinorgbio.2005.10.007","article-title":"The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model","volume":"100","author":"Brewer","year":"2006","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.redox.2025.103846_bib118","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jinorgbio.2004.10.006","article-title":"Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis","volume":"98","author":"Brewer","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.redox.2025.103846_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37031-1","article-title":"The copper chelator ammonium tetrathiomolybdate inhibits the progression of experimental endometriosis in TNFR1-Deficient mice","volume":"13","author":"Conforti","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2025.103846_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.700902","article-title":"Tetrathiomolybdate treatment attenuates bleomycin-induced angiogenesis and lung pathology in a sheep model of pulmonary fibrosis","volume":"12","author":"Derseh","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2025.103846_bib121","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.lab.2005.07.004","article-title":"Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice","volume":"146","author":"Hou","year":"2005","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.redox.2025.103846_bib122","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12011-014-0142-1","article-title":"The copper chelator tetrathiomolybdate regressed bleomycin-induced pulmonary fibrosis in mice, by reducing lysyl oxidase expressions","volume":"162","author":"Ovet","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.redox.2025.103846_bib123","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/biof.1837","article-title":"Copper chelation therapy inhibits renal fibrosis by modulating copper transport proteins","volume":"48","author":"Saifi","year":"2022","journal-title":"Biofactors"},{"key":"10.1016\/j.redox.2025.103846_bib124","first-page":"3","article-title":"Tetrathiomolybdate protects against liver injury from acetaminophen in mice","volume":"4","author":"Shaochun","year":"2004","journal-title":"J. Appl. Res. Clin. Exp. Therapeut."},{"key":"10.1016\/j.redox.2025.103846_bib125","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41586-023-06017-4","article-title":"A druggable copper-signalling pathway that drives inflammation","volume":"617","author":"Solier","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.redox.2025.103846_bib126","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2012.06.013","article-title":"Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-Deficient mice","volume":"223","author":"Wei","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.redox.2025.103846_bib127","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","article-title":"Copper-dependent autophagic degradation of GPX4 drives ferroptosis","volume":"19","author":"Xue","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2025.103846_bib128","article-title":"Tetrathiomolybdate partially alleviates erectile dysfunction of type 1 diabetic rats through affecting Ceruloplasmin\/eNOS and inhibiting corporal fibrosis and systemic inflammation","volume":"10","author":"Yin","year":"2022","journal-title":"Sex. Med."},{"key":"10.1016\/j.redox.2025.103846_bib129","first-page":"2501","article-title":"Tetrathiomolybdate is effective in a mouse model of arthritis","volume":"33","author":"McCubbin","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.redox.2025.103846_bib130","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1186\/ar1801","article-title":"Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats","volume":"7","author":"Omoto","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.redox.2025.103846_bib131","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jdermsci.2018.08.003","article-title":"Tetrathiomolybdate, a copper chelator inhibited imiquimod-induced skin inflammation in mice","volume":"92","author":"Hsu","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.redox.2025.103846_bib132","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.trsl.2009.09.009","article-title":"Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial","volume":"155","author":"Askari","year":"2010","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.redox.2025.103846_bib135","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-Amyloid accumulation in alzheimer's disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"issue":"20","key":"10.1016\/j.redox.2025.103846_bib136","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.3390\/ijms21207660","article-title":"Copper toxicity links to pathogenesis of alzheimer's disease and therapeutics approaches","volume":"21","author":"Ejaz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.redox.2025.103846_bib137","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4103\/NRR.NRR-D-24-00140","article-title":"Role of copper chelating agents: between old applications and new perspectives in neuroscience","volume":"20","author":"Leuci","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.redox.2025.103846_bib138","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3233\/JAD-2010-100408","article-title":"A copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of alzheimer's disease","volume":"21","author":"Quinn","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.redox.2025.103846_bib139","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12502","article-title":"Copper chelators promote nonamyloidogenic processing of A\u03b2PP via MT1\/2\/CREB-Dependent signaling pathways in A\u03b2PP\/PS1 transgenic mice","volume":"65","author":"Wang","year":"2018","journal-title":"J. Pineal Res."},{"issue":"32","key":"10.1016\/j.redox.2025.103846_bib140","first-page":"2246","article-title":"Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof","volume":"88","author":"Liu","year":"2008","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"5","key":"10.1016\/j.redox.2025.103846_bib141","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.pharep.2016.05.006","article-title":"Hydrogen sulfide down-regulates BACE1 and PS1 via activating PI3K\/Akt pathway in the brain of APP\/PS1 transgenic mouse","volume":"68","author":"He","year":"2016","journal-title":"Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.redox.2025.103846_bib142","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017225118","article-title":"Hydrogen sulfide is neuroprotective in alzheimer's disease by sulfhydrating GSK3\u03b2 and inhibiting tau hyperphosphorylation","volume":"118","author":"Giovinazzo","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.redox.2025.103846_bib143","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s12035-015-9212-4","article-title":"Hydrogen sulfide ameliorates homocysteine-induced alzheimer's disease-like pathology, blood\u2013brain barrier disruption, and synaptic disorder","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2025.103846_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102633","article-title":"Elevated plasma sulfides are associated with cognitive dysfunction and brain atrophy in human alzheimer's disease and related dementias","volume":"62","author":"Reekes","year":"2023","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.redox.2025.103846_bib145","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.24372","article-title":"Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis","volume":"77","author":"Davoli","year":"2015","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.redox.2025.103846_bib146","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.redox.2025.103846_bib147","first-page":"509","article-title":"PBT2 rapidly improves cognition in alzheimer's disease: additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J. Alz. Dis."},{"issue":"1","key":"10.1016\/j.redox.2025.103846_bib148","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1474-4422(14)70262-5","article-title":"Safety, tolerability, and efficacy of PBT2 in huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"14","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.redox.2025.103846_bib149","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of deferiprone in parkinson's disease","volume":"387","author":"Devos","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.redox.2025.103846_bib150","first-page":"S8","article-title":"Metabolic modulation by tetrathiomolybdate, a slow-release sulphide donor","volume":"38","author":"Dyson","year":"2012","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.redox.2025.103846_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002310","article-title":"Ammonium tetrathiomolybdate following ischemia\/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models","volume":"14","author":"Dyson","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.redox.2025.103846_bib152","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.bmcl.2016.02.005","article-title":"Ammonium tetrathiomolybdate as a water-soluble and slow-release hydrogen sulfide donor","volume":"26","author":"Xu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.redox.2025.103846_bib153","first-page":"31","article-title":"Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs","volume":"103","author":"Cirino","year":"2023","journal-title":"Phys. Rev."},{"key":"10.1016\/j.redox.2025.103846_bib154","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bcp.2017.09.010","article-title":"A timeline of hydrogen sulfide (H2S) research: from environmental toxin to biological mediator","volume":"149","author":"Szabo","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2025.103846_bib155","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?","volume":"16","author":"Wang","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2025.103846_bib156","doi-asserted-by":"crossref","DOI":"10.1126\/science.1108581","article-title":"H2S induces a suspended animation-like state in mice","volume":"308","author":"Blackstone","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.redox.2025.103846_bib157","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/SHK.0b013e31802e27a0","article-title":"Suspended animation-like state protects mice from lethal hypoxia","volume":"27","author":"Blackstone","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.redox.2025.103846_bib158","first-page":"183","article-title":"Surviving blood loss using hydrogen sulfide","volume":"65","author":"Morrison","year":"2008","journal-title":"J. Trauma"},{"key":"10.1016\/j.redox.2025.103846_bib159","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.resp.2007.09.001","article-title":"H2S induced hypometabolism in mice is missing in sedated sheep","volume":"160","author":"Haouzi","year":"2008","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.redox.2025.103846_bib160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/SHK.0b013e3181674185","article-title":"Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia\/reperfusion injury","volume":"30","author":"Simon","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.redox.2025.103846_bib161","author":"Mallinckrodt"},{"key":"10.1016\/j.redox.2025.103846_bib162","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10863-008-9166-6","article-title":"The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance","volume":"40","author":"Cooper","year":"2008","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.redox.2025.103846_bib163","article-title":"Hydrogen sulfide-mechanisms of toxicity and development of an antidote","volume":"6","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2025.103846_bib164","article-title":"Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics","volume":"38","author":"Paul","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103846_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101435","article-title":"A redox cycle with complex II prioritizes sulfide quinone oxidoreductase-dependent H2S oxidation","volume":"298","author":"Kumar","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2025.103846_bib166","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bcp.2017.11.014","article-title":"A review of hydrogen sulfide (H2S) donors: chemistry and potential therapeutic applications","volume":"149","author":"Powell","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2025.103846_bib167","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1079\/BJN19790050","article-title":"The behaviour of thiomolybdates in in vitro systems","volume":"41","author":"Weber","year":"1979","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.redox.2025.103846_bib168","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bph.14670","article-title":"Chemistry, pharmacology, and cellular uptake mechanisms of thiometallate sulfide donors","volume":"177","author":"Durham","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2025.103846_bib169","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12989-022-00467-w","article-title":"Copper oxide nanoparticles trigger macrophage cell death with misfolding of Cu\/Zn superoxide dismutase 1 (SOD1)","volume":"19","author":"Gupta","year":"2022","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.redox.2025.103846_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-023-01564-1","article-title":"Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway","volume":"9","author":"Qi","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.redox.2025.103846_bib171","first-page":"1","article-title":"Ammonium tetrathiomolybdate triggers autophagy-dependent NRF2 activation in vascular endothelial cells","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2025.103846_bib172","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3390\/ijms24043123","article-title":"Tetrathiomolybdate decreases the expression of alkaline phosphatase in dermal papilla cells by increasing mitochondrial ROS production","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.redox.2025.103846_bib173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2024.0595","article-title":"Superoxide is an intrinsic signaling molecule triggering muscle hypertrophy","volume":"42","author":"Lu","year":"2025","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2025.103846_bib174","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.freeradbiomed.2024.07.014","article-title":"Superoxide signal orchestrates tetrathiomolybdate-induced longevity via ARGK-1 in Caenorhabditis Elegans","volume":"222","author":"Zhou","year":"2024","journal-title":"Free Rad. Med. Biol."},{"key":"10.1016\/j.redox.2025.103846_bib175","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.redox.2025.103846_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20242074","article-title":"Therapeutic strategies to ameliorate mitochondrial oxidative stress in ischaemia\u2013reperfusion injury: a narrative review","volume":"139","author":"Alotaibi","year":"2025","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.redox.2025.103846_bib177","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40635-020-00300-8","article-title":"Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke","volume":"8","author":"Mendon\u00e7a","year":"2020","journal-title":"Inten. Care Med. Exp."},{"key":"10.1016\/j.redox.2025.103846_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103167","article-title":"Development and translation of thiometallate sulfide donors using a porcine model of coronary occlusion and reperfusion","volume":"73","author":"Johnson","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103846_bib179","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/ars.2011.4005","article-title":"Hydrogen sulfide in the mammalian cardiovascular system","volume":"17","author":"Liu","year":"2012","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2025.103846_bib180","first-page":"L44","article-title":"Cellular energy utilization and supply during hypoxia in embryonic cardiac myocytes","volume":"270","author":"Budinger","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.redox.2025.103846_bib181","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","article-title":"Reperfusion injury and reactive oxygen species: the evolution of a concept","volume":"6","author":"Granger","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103846_bib182","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","article-title":"Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo","volume":"4","author":"Murphy","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.redox.2025.103846_bib183","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa2100591","article-title":"Hypothermia versus normothermia after out-of-hospital cardiac arrest","volume":"384","author":"Dankiewicz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2025.103846_bib184","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00424-010-0811-7","article-title":"Glutathione peroxidase 1 protects mitochondria against Hypoxia\/Reoxygenation damage in mouse hearts","volume":"460","author":"Thu","year":"2010","journal-title":"Pflugers Arch - Eur. J. Physiol."},{"key":"10.1016\/j.redox.2025.103846_bib185","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1006\/jmcc.1996.0165","article-title":"Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury","volume":"28","author":"Yoshida","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9 Suppl","key":"10.1016\/j.redox.2025.103846_bib186","first-page":"216","article-title":"Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury","volume":"96","author":"Yoshida","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2025.103846_bib187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6494306","article-title":"H2S protects against cardiac cell hypertrophy through regulation of selenoproteins","volume":"2019","author":"Greasley","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.redox.2025.103846_bib188","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","article-title":"The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer","volume":"1","author":"Kansanen","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103846_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102726","article-title":"The KEAP1-NRF2 pathway: targets for therapy and role in cancer","volume":"63","author":"Adinolfi","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103846_bib190","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2025.103846_bib191","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2337\/db16-0020","article-title":"Hydrogen sulfide induces Keap1 S-sulfhydration and suppresses diabetes-accelerated atherosclerosis via Nrf2 activation","volume":"65","author":"Xie","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2025.103846_bib192","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","article-title":"Hydrogen sulfide mediates cardioprotection through Nrf2 signaling","volume":"105","author":"Calvert","year":"2009","journal-title":"Circ. Res."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725003593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725003593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:53:47Z","timestamp":1763646827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725003593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":186,"alternative-id":["S2213231725003593"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103846","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms, therapeutic uses, and developmental perspectives of redox-active thiomolybdates","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103846"}}